OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents
Kenneth C. P. Cheung, Jiao Ma, Rodrigo Azevedo Loiola, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 7
Kenneth C. P. Cheung, Jiao Ma, Rodrigo Azevedo Loiola, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 7
Showing 7 citing articles:
Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics
Arthur S. McMillan, Casey M. Theriot
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Arthur S. McMillan, Casey M. Theriot
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy
Miljana Nenkov, Yihui Shi, Yunxia Ma, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 6-6
Open Access | Times Cited: 5
Miljana Nenkov, Yihui Shi, Yunxia Ma, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 6-6
Open Access | Times Cited: 5
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Yung-Ni Lin, Jia‐Rou Hsu, Chih-Lin Wang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Yung-Ni Lin, Jia‐Rou Hsu, Chih-Lin Wang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies
Yue Yin, Weibo Feng, Xilang Chen, et al.
The Innovation Medicine (2024), pp. 100092-100092
Closed Access | Times Cited: 1
Yue Yin, Weibo Feng, Xilang Chen, et al.
The Innovation Medicine (2024), pp. 100092-100092
Closed Access | Times Cited: 1
Thalidomide mitigates Crohn's disease colitis by modulating gut microbiota, metabolites, and regulatory T cell immunity
Chao‐Tao Tang, Yonghui Wu, Tao Qing, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101121-101121
Open Access
Chao‐Tao Tang, Yonghui Wu, Tao Qing, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101121-101121
Open Access
Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
Samantha Hsieh, Arun Chandnani, Siyan Cao
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2910-2910
Open Access
Samantha Hsieh, Arun Chandnani, Siyan Cao
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2910-2910
Open Access
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Li‐Ling Wu, Yung-Ni Lin, Jia‐Rou Hsu, et al.
Research Square (Research Square) (2023)
Open Access
Li‐Ling Wu, Yung-Ni Lin, Jia‐Rou Hsu, et al.
Research Square (Research Square) (2023)
Open Access
